|
|
|
Insider
Information: |
Kariv Tomer |
Relationship: |
Director, 10% Owner |
City: |
Flemington |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
11,314,671 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$6,289,012 |
|
|
Total
Shares |
11,314,671 |
|
|
Total
Value |
$6,289,012 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arno therapeutics Inc |
ARNI |
Director |
|
0 |
2016-08-15 |
496,068 |
Premium* |
|
Eloxx Pharmaceuticals Inc |
ELOX |
Director |
2018-03-21 |
0 |
2021-05-13 |
7,804,778 |
Premium* |
|
Logicbio Therapeutics, Inc. |
LOGC |
Director |
2018-10-23 |
0 |
2018-10-23 |
1,787,413 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
Director, 10% Owner |
|
0 |
2022-11-29 |
1,226,412 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KROS |
Keros Therapeutics, Inc. |
Director |
|
2022-11-29 |
4 |
OE |
$0.00 |
$1 |
I/I |
7,176 |
1,226,412 |
0 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2021-05-13 |
4 |
B |
$1.35 |
$7,999,999 |
I/I |
5,925,925 |
616,592 |
2.1 |
- |
|
KROS |
Keros Therapeutics, Inc. |
Director |
|
2020-04-13 |
4 |
B |
$16.00 |
$6,999,984 |
I/I |
437,499 |
149,262 |
2.25 |
- |
|
KROS |
Keros Therapeutics, Inc. |
Director |
|
2020-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
3,545,100 |
105,512 |
0 |
- |
|
KROS |
Keros Therapeutics, Inc. |
Director |
|
2020-04-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
751,908 |
|
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2019-06-24 |
4 |
B |
$9.00 |
$1,800,000 |
I/I |
200,000 |
24,000 |
2.1 |
- |
|
LOGC |
Logicbio Therapeutics, In... |
Director |
|
2018-10-23 |
4 |
B |
$10.00 |
$4,200,000 |
I/I |
420,000 |
1,787,413 |
2.1 |
- |
|
LOGC |
Logicbio Therapeutics, In... |
Director |
|
2018-10-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,367,413 |
1,367,413 |
0 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2018-04-30 |
4 |
B |
$9.75 |
$3,412,500 |
I/I |
350,000 |
520,396 |
2.1 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2018-03-22 |
4 |
B |
$8.00 |
$48,000 |
I/I |
6,000 |
427,063 |
2.1 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2018-03-21 |
4 |
B |
$7.55 |
$49,830 |
I/I |
6,600 |
425,463 |
2.1 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2016-08-15 |
4 |
B |
$0.00 |
$0 |
I/I |
714,285 |
496,068 |
2.02 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2016-01-12 |
4 |
B |
$0.35 |
$506,822 |
I/I |
1,448,062 |
393,968 |
2.1 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2013-10-29 |
4 |
OE |
$2.40 |
$1,066,445 |
I/I |
444,352 |
122,660 |
0 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2013-10-29 |
4 |
A |
$2.40 |
$79,997 |
I/I |
33,332 |
127,424 |
0 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2013-10-29 |
4 |
B |
$0.00 |
$0 |
I/I |
416,666 |
186,982 |
2.02 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2013-05-28 |
4 |
A |
$0.30 |
$20,000 |
I/I |
66,666 |
473,156 |
0 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2013-04-29 |
4 |
A |
$0.30 |
$34,192 |
I/I |
113,972 |
463,627 |
0 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2013-03-27 |
4 |
A |
$0.30 |
$20,000 |
I/I |
66,666 |
447,336 |
0 |
- |
|
ARNI |
Arno therapeutics Inc |
Director |
|
2013-01-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,062,875 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|